Companies: 10,795·Total market cap: $144.5T
Aethlon Medical, Inc.

Aethlon Medical, Inc.

AEMDNASDAQHealthcare● Active
$2.03
+$0.12(+6.28%)
Market Cap$1545400
P/E Ratio
52W High$28.8
52W Low$1.36

Aethlon Medical, Inc. (AEMD) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · AEMD · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Aethlon Medical, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

AEMD insider buying and selling by quarter

AEMD insider selling · AEMD insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
429K214K0
2025 Q2
2025 Q3
2025 Q4
2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · AEMD ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

AEMD executive sell shares · AEMD board member insider trading · AEMD insider trading SEC filing

Showing 87 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Rossetti Angela

Director

Award

Date

Apr 17

Shares

21,815

Price

$2.29

Value

$50K

View Form 4 on SEC.gov

Shah Chetan

Director

Award

Date

Apr 17

Shares

21,815

Price

$2.29

Value

$50K

View Form 4 on SEC.gov

BROENNIMAN EDWARD G

Director

Award

Date

Apr 17

Shares

21,815

Price

$2.29

Value

$50K

View Form 4 on SEC.gov

Gikakis Nicolas

Director

Award

Date

Apr 17

Shares

21,815

Price

$2.29

Value

$50K

View Form 4 on SEC.gov

Shah Chetan

Director

Other

Date

Mar 31

Shares

178

Price

$2.19

Value

$390

View Form 4 on SEC.gov

Gikakis Nicolas

Director

Other

Date

Mar 31

Shares

178

Price

$2.19

Value

$390

View Form 4 on SEC.gov

BROENNIMAN EDWARD G

Director

Other

Date

Mar 31

Shares

89

Price

$2.19

Value

$195

View Form 4 on SEC.gov

Shah Chetan

Director

Other

Date

Dec 31

Shares

179

Price

$2.77

Value

$496

View Form 4 on SEC.gov

Gikakis Nicolas

Director

Other

Date

Dec 31

Shares

179

Price

$2.77

Value

$496

View Form 4 on SEC.gov

BROENNIMAN EDWARD G

Director

Other

Date

Dec 31

Shares

89

Price

$2.77

Value

$247

View Form 4 on SEC.gov

Shah Chetan

Director

Other

Date

Sep 30

Shares

1,786

Price

$0.75

Value

$1K

View Form 4 on SEC.gov

Gikakis Nicolas

Director

Other

Date

Sep 30

Shares

1,786

Price

$0.75

Value

$1K

View Form 4 on SEC.gov

BROENNIMAN EDWARD G

Director

Other

Date

Sep 30

Shares

893

Price

$0.75

Value

$669

View Form 4 on SEC.gov

BROENNIMAN EDWARD G

Director

Other

Date

Jun 30

Shares

893

Price

$1.20

Value

$1K

View Form 4 on SEC.gov

Gikakis Nicolas

Director

Other

Date

Jun 30

Shares

1,786

Price

$1.20

Value

$2K

View Form 4 on SEC.gov

Shah Chetan

Director

Other

Date

Jun 30

Shares

1,786

Price

$1.20

Value

$2K

View Form 4 on SEC.gov

Gikakis Nicolas

Director

Award

Date

Apr 23

Shares

142,857

Price

$0.35

Value

$50K

View Form 4 on SEC.gov

Rossetti Angela

Director

Award

Date

Apr 23

Shares

142,857

Price

$0.35

Value

$50K

View Form 4 on SEC.gov

BROENNIMAN EDWARD G

Director

Award

Date

Apr 23

Shares

142,857

Price

$0.35

Value

$50K

View Form 4 on SEC.gov

Shah Chetan

Director

Award

Date

Apr 23

Shares

142,857

Price

$0.36

Value

$51K

View Form 4 on SEC.gov

BROENNIMAN EDWARD G

Director

Other

Date

Mar 31

Shares

1,645

Price

$0.36

Value

$589

View Form 4 on SEC.gov

Shah Chetan

Director

Other

Date

Mar 31

Shares

3,289

Price

$0.36

Value

$1K

View Form 4 on SEC.gov

Gikakis Nicolas

Director

Other

Date

Mar 31

Shares

3,289

Price

$0.36

Value

$1K

View Form 4 on SEC.gov

BROENNIMAN EDWARD G

Director

Other

Date

Dec 31

Shares

1,645

Price

$0.86

Value

$1K

View Form 4 on SEC.gov

Shah Chetan

Director

Other

Date

Dec 31

Shares

3,289

Price

$0.86

Value

$3K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About AEMD insider trading

AEMD insider trades

Aethlon Medical, Inc. (AEMD) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Shah Chetan (Director), BROENNIMAN EDWARD G (Director), Gikakis Nicolas (Director). Over the past 12 months, 4 insiders have filed transactions with the SEC. AEMD insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Aethlon Medical, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

AEMD insider trading · 5 questions

The insiders of Aethlon Medical, Inc. (AEMD) include executives and directors such as Shah Chetan (Director), BROENNIMAN EDWARD G (Director), Gikakis Nicolas (Director), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

AEMD board member insider tradingwho are AEMD insidersAEMD insider rosterAethlon Medical, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026